Literature DB >> 28562571

Hemodynamic instability after pulmonary veins isolation in a patient with dual chamber pacemaker: The phantom injury of the ventricular lead.

Márcio Galindo Kiuchi1, Guilherme Miglioli Lobato, Shaojie Chen.   

Abstract

INTRODUCTION: The standard treatment of sinus node dysfunction (SND) is the pacemaker implantation, and the ideal methodology for the management of atrial fibrillation (AF) is rhythm control, but this is sometimes very hard to accomplish. For such actions, complete isolation of all pulmonary veins (PVI) is currently widely accepted as the best endpoint. CASE
PRESENTATION: In this case, we report a female patient, 81 years old, with controlled hypertension, without coronary artery disease, bearer of bilateral knee replacement, and dual chamber pacemaker implanted 1.5 years ago owing to sinus node disease, presenting the following symptoms: presyncope episodes associated with sustained irregular palpitation tachycardia. The evaluation of the pacemaker-recorded episodes of atrial fibrillation, the echocardiogram-presented normal systolic function and measurements, as well as the resting myocardial scintigraphy and with drug use did not demonstrate ischemia and/or fibrosis. The patient was in use of valsartan 320 mg daily, amlodipine 10 mg daily, sotalol hydrochloride 120 mg 2 times daily, and dabigatran 110 mg 2 times daily. At the end of the PVI, the patient presented hemodynamic instability, with a decrease in heart rate to 30 bpm and invasive arterial blood pressure to 60/30 mmHg. The pericardial puncture was quickly carried out with the possibility of cardiac tamponade as the first hypothesis, but no pericardial effusion was found. Next, we detected acute capture loss from the ventricular pacemaker lead, unvarying with high voltage and pulse width, even with stable impedance, sense and keeping the same position visualized by fluoroscopy. And there was soon afterwards induction of sustained ventricular tachycardia degenerating to spontaneous ventricular fibrillation. Electrical cardioversion-defibrillation was performed with 200J, and the sinus rhythm was reestablished, but there was a dead short, and the pacemaker generator was burned and disabled.
CONCLUSIONS: So, we can speculate that application of atrial radiofrequency for PVI diffused through the tissues, affecting in some way the tip of the ventricular electrode, causing a microlesion in this structure and making it impossible to capture the right ventricle by the pacemaker. As we cannot see it, we can call it of phantom injury of the ventricular lead.

Entities:  

Mesh:

Year:  2017        PMID: 28562571      PMCID: PMC5459736          DOI: 10.1097/MD.0000000000007060

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  8 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

2.  The etiology of sino-atrial disorder (Sick Sinus Syndrome).

Authors:  D B Shaw
Journal:  Am Heart J       Date:  1976-10       Impact factor: 4.749

3.  The sick sinus syndrome in atrial disease.

Authors:  M I Ferrer
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

4.  Survival in sinoatrial disorder (sick-sinus syndrome).

Authors:  D B Shaw; R R Holman; J I Gowers
Journal:  Br Med J       Date:  1980-01-19

5.  Current concepts and management of the sick sinus syndrome.

Authors:  K E Nieminski; R H Kay; D A Rubin
Journal:  Heart Lung       Date:  1984-11       Impact factor: 2.210

6.  Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST).

Authors:  Taya V Glotzer; Anne S Hellkamp; John Zimmerman; Michael O Sweeney; Raymond Yee; Roger Marinchak; James Cook; Alexander Paraschos; John Love; Glauco Radoslovich; Kerry L Lee; Gervasio A Lamas
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

7.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

8.  The sinus node function: normal and pathological.

Authors:  M de Marneffe; J M Gregoire; P Waterschoot; M P Kestemont
Journal:  Eur Heart J       Date:  1993-05       Impact factor: 29.983

  8 in total
  1 in total

1.  Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review.

Authors:  Abdullah Alrumayh; Muath Alobaida
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.